u-Centrally released arginine vasopressin (AVP) has been implicated in the regulation of intracranial pressure (ICP) and brain water, and is elevated in the cerebrospinal fluid (CSF) of some patients with pseudotumor cerebri or subarachnoid hemorrhage. The authors have examined the relationship of AVP levels in CSF to ICP and brain water content in three experimental groups of cats with and without cold-induced vasogenic edema. With the cats under general anesthesia, a cold lesion was made and cannulas were placed in the cisterna magna, lateral ventricle, and aorta. Subsequent central and systemic measurements were made while the animals were awake and free-roaming.
I
T has been theorized that centrally released arginine vasopressin (AVP) is involved in the regulation of intracranial pressure (ICP) and brain water content. 5'z2 '24 Earlier experiments have demonstrated the existence of extrahypophyseal vasopressinergic pathways within the central nervous system 2'3,33'41 which might allow for the independent release and function of central versus systemic AVP. 634 '19'29 These observations led to more direct examination of the relationship of AVP to brain water regulation. Centrally administered AVP has been reported to increase brain capillary permeability in monkeys 25 and brain water content in rats. 5 It has also been shown to decrease ICP in rabbits 2~ and to accelerate clearance of cerebrospinal fluid (CSF) from ventricles to blood in rabbits and cats. ~' 2~' 22 Summary interpretation of these apparently conflicting results is confounded by the lack of concurrent measurement of ICP and brain water content in any one species.
In clinical studies, increased CSF levels of AVP have been reported in association with pseudotumor cerebri TM and with some instances of subarachnoid hemorrhage (SAH) induced by aneurysmal rupture. "'~7 It may be questioned whether CSF AVP plays a causative, adaptive, or epiphenomenal role in these pathological situations. Although there is recent evidence that, following experimental SAH, Brattleboro rats with diabetes insipidus develop brain edema to a different degree than do normal rats, 4 there are no studies in which the effects of CSF AVP on brain edema have been directly observed. This study was designed to investigate further the potential relationship of central AVP to ICP and brain water content in normal and pathological circumstances. Our goals included: 1) the development of a reproducible model of cold-induced vasogenic edema; 2) concurrent measurement of ICP, CSF AVP levels, and brain water content in each animal, with the additional recording of systemic values that might affect these central measurements; and 3) avoidance of anesthesia-induced changes in central AVP release, as documented in the literature. 32 Accordingly, our measurements were made in unanesthetized, unrestrained adult cats after recovery from general anesthesia induced for the placement of indwelling catheters and the production of cold lesions. In the first of three experiments, we observed whether vasogenic brain edema affects endogenous CSF AVP levels as compared to those of unlesioned sham-operated control animals. In the second and third experiments, we examined the effects of repeated intraventricular AVP injections on the abovedescribed central and systemic measurements in animals with and without vasogenic brain edema.
Materials and Methods

Animal Preparation
This study was performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was further approved by the Dartmouth Medical School Animal Review Committee. In addition, constant postoperative care was maintained by the principal investigator for the duration of each experiment. Adult female and male cats, ranging in weight from 2.2 to 3.8 kg each, were anesthetized with 96% oxygen and 4% halothane, intubated orotracheally, and then maintained on 30% oxygen, 69% nitrous oxide, and 1% halothane. The cephalic vein was catheterized percutaneously for venous access, and the animals were paralyzed with intravenous gallamine, using 5 mg/kg initially and an additional 1 mg/kg every 89 to 1 hour as needed. Mechanical ventilation was accomplished with a Harvard respirator.* To ensure adequate hydration and to counterbalance the mild hypotension and metabolic acidosis encountered in anesthesia and surgery, 40 ml/kg of lactated Ringer's solution was administered intravenously during the 1 st hour, followed by an additional 20 ml/kg over the remaining operative period; 2 mEq/kg of sodium bicarbonate was also given by intravenous bolus at the initiation of the procedure. Body temperature was monitored and maintained by a Yellow Springs proportional temperature controllert using an infrared lamp as the heat source. Aseptic techniques were used for all cannula placements. Catheter tubing (PE 100) was inserted into the superficial femoral artery and threaded into the aorta. The distal end was passed subcutaneously from the groin to the back of the neck, exiting there. Arterial blood gases were measured on a Radiometer BMS 3 blood gas analyzer:~ during the procedure and normalized by respiratory changes. The pCO2 in the cat is normally about 30 torr. The animal was then placed in a stereotaxic head holderw for further cannula placement and frontal craniotomy.
A chronic cisterna magna cannula was fashioned in the following manner. Microrenathane, U a soft kinkresistant tubing, was heated over a flame at one point and then rapidly drawn apart (similar to the method of creating micropipettes with glass capillary tubes) to produce a tapered closed blunt tip. A fine rongeur was used to cut three small holes in alternating sides of the cannula at distances of 1, 3, and 5 mm from its tip. A mark was made 6 mm from the tip with indelible ink to ensure consistent placement of the cannula. With the cat's head at 45* flexion, the atlanto-occipital membrane was exposed through a midline incision in the skin and the suboccipital muscle groups. A 6-0 silk suture on an atraumatic needle was used to place a vertical Z-stitch through the membrane only, not including the underlying arachnoid membrane. Both membranes were incised with a No. 22 needle used as a scalpel, and the cannula was quickly placed into the cisterna magna by means of a curved blunt probe inserted through the hole closest to the cannula tip as a stylet. Once the tip was within both membranes, the stylet was removed and the cannula was easily threaded into the cistern until the mark at 6 mm was reached. The stitch was then tied around the tubing to act as a pursestring to seal the membrane around the cannula. Cyanoacrylate glue was placed at the entry site to further aid in preventing CSF leakage. The tubing was turned upward and fixed to the occipital bone with the same tissue adhesive. Muscle and skin were sutured closed leaving 1.5 cm of cannula exposed through the skin at the occipital protuberance. Sterile steel pins were inserted into the tubing to keep the system closed. Later autopsies revealed the cannula tip to be consistently just within the caudal aspect of the fourth cerebral ventricle.
For animals in Experiments 2 and 3 (see below), the head was returned to a neutral position for stereotaxic insertion of a stainless steel cannula* into the left lateral ventricle. The Horsley-Clarke coordinates of 14.5 mm anterior, 2.5 mm lateral, and 7.0 mm dorsal at a vertical angle were used, with the actual length of the cannula being 14 mm. ~8 Correct cannula placement was confirmed during surgery by the rapid fall in a column of sterile normal saline attached to the cannula and at the end of the experiment by dye injection. The cannula itself was screwed firmly into the parietal bone and its hub remained above the skin closure. A self-sealing rubber membrane within the cannula allowed for repeated intraventricular injections. Finally, in Experiments 1 and 3 (see below), a craniotomy was performed through the left frontal sinus, exposing a circle of dura mater 1 cm in diameter. After appropriate manipulations to the brain, this craniotomy was closed with Hygenic dental cement, filling the sinus. One ml/kg of 2% Evans blue dye was given intravenously to aid in assessing the degree of edema spread. The animals were allowed to recover and were then extubated and placed in individual cages for the remainder of the experiment. The operative procedure with baseline measurements typically required 2 89 hours.
Experimental Groups
Experiment I. To test the response of endogenous CSF AVP to cold-induced vasogenic edema, 17 animals received a cold lesion while under general anesthesia. A Cryomedics cryosurgical probe? was applied to the dura mater at the left frontal craniotomy site, producing a temperature of -30*C. A probe with a diameter of 4 mm was applied for 2 minutes in five cats, and a 9-mm probe was applied for 3 minutes in seven cats. Five control animals received a sham craniotomy but no cold lesion. Baseline (0-hour) values were obtained in the anesthetized animals after normalization of arterial blood gases and just prior to application of the cold probe. Mean arterial blood pressure (BP), ICP, and arterial blood gases were measured at 0, ~, 6, 12, 24, 36, and 48 hours. Because of reported diurnal variation in the CSF AVP levels of cats, 29 initial values were determined within 2 hours of noon. Animals in this experiment were allowed free access to water. They were sacrificed at 48 hours by intravenous injection of pentobarbital followed by KC1, and the brains were removed for water analysis.
Experiment 2. To measure the response of brain water content and ICP to exogenous AVP in cats without cold lesions, three groups of animals, five in each group, received 50-~1 intraventricular injections of either cartier (6 ~M acetic acid in 0.9% NaC1 solution) or 1.5 ng or 30 ng AVP every 2 hours for a 24-hour period. Each injection was followed by 50 gl of normal saline to insure complete AVP delivery to the animal. The initial injection was made under anesthesia after normalization of arterial blood gases. Baseline (0-hour) measurements were obtained prior to AVP delivery. The ICP, BP, arterial blood gases, pulse rate, and hematocrit were measured at 0, 89 6, 12, 18, and 24 hours. In addition, serum sodium levels were obtained at 24 hours. Water intake was not allowed during the experiment. The animals were sacrificed and the brains removed for water analysis at 24 hours. At both 12 and 24 hours a 300-~1 cisternal CSF sample was withdrawn after ICP measurement and before reinjection for AVP analysis to indicate approximate trough levels. Also at 24 hours, CSF was taken 5 minutes after injection of AVP for determination of approximate peak levels.
Experiment 3. To determine the response of vasogenic edema and ICP to exogenous AVP in cold-lesioned cats, three groups of animals, five in each group, were injected exactly as those in Experiment 2, with carrier and two different doses of AVP. In addition, a cold lesion was produced with the 9-mm probe applied for 3 minutes through a left frontal craniotomy. The actual measured low and high doses of AVP delivered in this experiment were 2.0 and 35 ng, respectively.
Data Collection and Analysis
The ICP was measured while each cat reclined in its cage with its head level and the transducer zeroed at the external auditory canal. Values for mean ICP were recorded after continuous monitoring of ICP over approximate 5-minute periods. A value was recorded when it was duplicated over more than five respiratory cycles. This procedure resulted in consistently reproducible ICP values on repeated measurements in the same animal. Blood pressure measurements were made during end expiration with the transducer zeroed at the level of the heart. Gould P23id transducers were used with a Gould two-channel recording system~, for recording both ICP and BP.
Brain water analysis was accomplished by modification of a technique described by Reulen, et al.3~ After brain removal, a 3-mm thick horizontal slice through the brain centering on the lesioned area in the left frontal pole was made utilizing parallel microtome blades. Bands of tissue 3-mm thick extending from the frontal cortex anteriorly to the hippocampus posteriorly were then dissected from both the lesioned and unlesioned hemispheres (Fig. 1) . Each band was further divided into two 3 x 3 x 9-mm white matter strips, after the frontal gray matter cortex was discarded. These four strips of white matter were closely inspected for any contaminating areas of gray matter, which were then excised. Wet weights for the strips adjacent to and distant from the frontal cortex in the hemispheres both ipsilateral and contralateral to the cold lesion were obtained using a Mettler balance. The tissue was then oven-dried at 60~ to a constant weight. Brain water content is expressed as a percentage as follows: wet weight -dry weight/wet weight x 100.
Analysis of AVP levels in CSF was performed using radioimmunoassay techniques described elsewhere. 2~ Plasma sodium concentration was measured by flame photometry.w An analysis of variance with Bonferroni modified t-statistics was used for all data. 3s
Pressure transducer recording system manufactured by Gould, Inc., Cleveland, Ohio.
w Flame photometry system manufactured by Radiometer A/S, Emdrupvej 72, DK2400, Copenhagen, Denmark. 
Results
Experiment 1
In this experiment, two degrees of vasogenic edema were created to observe the possible effect of edema on large-cavity CSF AVP levels. In cats with lesions created by the 4-ram probe, a significant elevation in water content (p < 0.01) was measured in tissue adjacent to but not distant from the lesion, as compared to shamoperated control animals ( Fig. 2A) . Although this lesion caused a mild elevation in ICP for the 48-hour period (Fig. 2B) , the increase was not significant. Lesioning with the 9-mm probe produced significant elevation in water content of both adjacent (p < 0.01) and distant (p < 0.01) areas ( Fig. 2A) , and significantly elevated ICP (p < 0.01) throughout the experiment (Fig. 2B) . Neither type of edema affected brain water content in the contralateral hemisphere.
Measurement of cisternal CSF AVP levels revealed no significant difference at any time among the groups (Fig. 2C) . In all groups, we observed a marked elevation of levels during anesthesia and surgery. These values had returned to baseline 6 hours after surgery. After recovery from anesthesia, a diurnal variation in AVP level was seen in all animals (2 to 18 pg/ml), with day values being higher than night. No significant differences were found in arterial pH, pCO2, pO2, or mean BP among the groups.
Experiment 2
Brain water content of normal white matter was similar among low-dose AVP, high-dose AVP, and cartier-injected animals without cold lesions (Fig. 3A) . The ICP was significantly lower at 24 hours in the highdose animals as compared to both the low-dose (p < 0.05) and control (p < 0.01) groups (Fig. 3B) .
Analysis of CSF AVP revealed average trough and peak levels (+ standard error of the mean) of 100 ___ 23 R. F. Reeder, E. E. Nattie and W. G. North pg/ml and 579 + 141 pg/ml for the low dose, and 1.4 + 0.4 ng/ml and 12.2 _+ 3.9 ng/ml for the high dose (Table 1) . No significant differences between pH, pCO2, p02, mean BP, pulse rate, 24-hour serum sodium level, or hematocrit were seen at any time period (Fig.  4 and Table 2 ).
Experiment 3
In cold-injured animals injected with either low-dose or high-dose AVP, brain water was significantly ele- vated in areas adjacent to and distant from the lesion (p < 0.05) as compared to the carrier-treated control cats with cold lesions (Fig. 5A) . A significant difference of water content between groups receiving the low and high dose was approached in the distant tissue samples, with a p value of < 0.08. No differences were seen in the water content of the contralateral hemispheres among the groups.
Vasopressin in cold-induced brain edema
The ICP measured in the low-dose group was consistently lower than in control animals, while high-dose AVP produced consistently higher ICP values at 12 and 18 hours (Fig. 5B ). Significant differences were seen in comparing the ICP of the high-dose group to that of the low-dose group at 12 hours (p < 0.01) and to both the low-dose and control groups at 18 hours (p < 0.01 and p < 0.05, respectively). The change in ICP of the low-dose group approached significance compared to control at 18 hours (p < 0.06).
Clinically, animals receiving carrier injection demonstrated a mild right hemiparesis, whereas, in addition to the hemiparesis, one of five animals receiving lowdose AVP and two of five receiving high-dose AVP showed evidence of brain-stem impaction. Mild impaction by transtentorial herniation was suspected in these three animals by the appearance of left-sided pupillary dilatation and was confirmed at the time of brain removal by the presence of uncal notching.
The trough and peak levels of CSF AVP averaged 140 + 24 pg/ml and 681 ___ 165 pg/ml for the low dose, and 1.5 ___ 0.5 ng/ml and 11.9 + 1.0 ng/ml for the high 9.2 _+ 2.5 pg/ml 100 + 23to 579 ~-141 pg/ml 1.4 ___ 0.4to 12.2 + 3.9 ng/ml 5.9 + 1.0 pg/ml 140 _ 24to 681 + 165 pg/ml 1.5 +__ 0.5 to 11.9 + 1.0 ng/ml * Arginine vasopressin (AVP) was centrally administered every 2 hours for 24 hours in the low-and high-dose groups, and trough and peak levels in cerebrospinal fluid (CSF) were determined. Animals receiving carrier solution injections had CSF AVP levels determined at 24 hours only. Values are means _+ standard error of the means. For further description of experiments see text. (Table 1) . Again, no differences were seen in pH, pCO2, pO2, mean BP, pulse rate, 24-hour serum sodium level, or hematocrit ( Fig. 6 and Table 2 ).
Discussion
The hypothesis that central AVP has a role in brain water regulation is not new. 24 Investigations testing this theory stemmed from earlier anatomical and physiological observations that supported separate functions of central versus systemic AVP. First, AVP was found at significant levels in the CSF, 7'9'40 arriving there by direct secretion from the brain and not by entry from the systemic circulation. 6'~4 Second, extrahypophyseal vasopressinergic pathways were found to exist from the hypothalamus and suprachiasmatic nucleus to areas of the brain involved in CSF production (choroid plexus), 2'3 to the locus ceruleus (a region postulated to be involved in noradrenergic control of brain capillary permeability), 26 
FIG. 4. Graphic representations of systemic values in Experiment 2
, in which the response of brain water content and intracranial pressure to exogenous arginine vasopressin (AVP) was studied in cats without cold lesions. Values are means + standard error of the means. The mean blood pressure (BP) (A), pulse rate (B), pCO2 (C), and pH (D) values measured at 6-hour intervals in unlesioned animals with low-or high-dose intraventricular injections of AVP are compared to those of unlesioned carrier-injected control animals. The measurements at 0 hour were made while animals were anesthetized. No differences were found between groups at any given time.
CSF AVP is known to vary independently from plasma AVP in many circumstances 6"29' 37' 39 and is likely to be subject to separate releasing mechanisms. Therefore, central vasopressin has the potential for direct neuronal contact, or for contact via CSF flow, with multiple effector sites of brain water regulation.
Based on experimental data implicating central AVP in brain water 5'22'25 and ICP 2~ regulation, and on studies in humans showing small but significant increases in CSF AVP in patients with pseudotumor cerebri 8'34 and in some cases of SAH, ~ ~,17 we questioned whether AVP levels in CSF might be increased as a result of vasogenic brain edema. We found no change in CSF AVP levels in cats with cold-induced vasogenic edema, with or without elevated ICP, as compared to control animals. Although our data do not support a strong cause-andeffect relationship, it is possible that more severe edema or ICP elevation or more sensitive methods of measurement (for instance, determination of tissue AVP levels in appropriate locations versus large-cavity CSF levels) would show such a relationship. In addition, our study confirms both the effect of anesthetics on elevating AVP levels in CSF 32 and the existence of a CSF AVP diurnal rhythm in adult catsfl 9 Accordingly, each experiment was begun at approximately the same time of day to minimize the influence of this rhythm on potential ICP-and edema-induced differences in CSF AVP levels. Nonetheless, the day-night variation may have hidden any small effects of the edema-producing lesions on CSF AVP.
Further experiments involving repeated injections of AVP into the cerebral ventricles over a 24-hour pe- riod were performed to observe the effect that central AVP has on water content and ICP in animals with and without vasogenic brain edema. The effect of AVP on brain water content appears clear; pharmacological levels of CSF AVP, as generated in both the high-and low-dose groups, caused a further increase of brain water content in edematous but not in normal white matter. The difference in water content between the cold-injured high-and low-dose groups approached significance in the distant tissue sample, with a p value of < 0.08. Therefore our data suggest, but do not prove, a dose-response relationship between CSF AVP levels and the facilitation of vasogenic brain edema formation.
There are many possible mechanisms by which AVP can increase edema. Cold-induced vasogenic edema resuits principally from a marked increase in brain capillary permeability, which allows movement of both solutes and water from plasma to brain/3'3~ The rate and extent of edema formation are multifactorial and have been mathematically described by Rapoport. 27 These factors include osmotic and hydrostatic pressures, tissue compliance, and capillary and tissue hydraulic conductivities. The literature would suggest that central AVP causes an increase in edema by enhancing an already increased capillary water permeability. Raichle and Grubb 25 used a single-capillary transit model in anesthetized rhesus monkeys to determine changes in brain capillary permeability and cerebral blood flow. While there was no change in blood flow, a single 5-ug intraventricular injection of AVP resulted in a rise of capillary permeability which was sustained for 30 minutes. In the present study, measurement of arterial blood gases, mean BP, serum sodium levels, and hematocrit does not support a hydrostatic or osmotic cause of edema enhancement, although more direct observations of these parameters (such as by cerebral blood flow) were not made. Furthermore, we cannot comment on the possible effect of AVP on brain tissue compliance or hydraulic conductance. Nonetheless, we believe our data, together with those of Raichle and Grubb, 25 make the hypothesis that AVP induces increased edema by causing further increases in capillary permeability a tenable one.
Given this mechanism, it might be questioned why we have not observed AVP-induced changes in the brain water content of normal animals. We believe that, because of the increased compliance and hydraulic conductivity of edematous white matter, 3~ a further small increment in permeability could be reflected by measurable changes in water contentY In normal white matter in which compliance and hydraulic conductivity are quite low, small increases in permeability would not be expected to cause measurable water changes. Indeed, no increase in normal white matter water content occurred in the presence of 35-ng intraventricular injections of AVP every 2 hours for 24 hours. In contrast, D6czi, et al., 5 reported an increase of 1.3% in wholebrain water content 90 minutes following delivery of a single intraventricular bolus of 125 ng AVP or 0.5 #g desmopressin acetate to normal anesthetized adult rats. We wonder whether this increase in water content was limited to gray matter (the rat brain is predominantly gray matter), which is the expected site of vasogenic edema secondary to either transient large increases or prolonged small increases in capillary permeability. 28 Because of the very low compliance and conductance of both normal and edematous gray matter, hours or even days of low-level capillary barrier opening may be needed before edema will transfer from gray to white matter. Unfortunately, gray matter changes were not recorded in the present study.
The mechanism of action for AVP-induced changes in capillary permeability is poorly defined. To date, very little is known about the location of vasopressin receptors in the brain and none have been demonstrated on brain vasculature, nor is there evidence of vasopressinergic pathways to vessels? 9 There is evidence suggesting AVP does not have a direct effect on brain capillaries. Herbst, et al., ~~ examined cyclic adenosine monophosphate (cAMP) production in response to AVP and neurotransmitters in isolated in vitro brain microvessels. They proposed that an elevation in cAMP would indicate which agents might influence brain capillary permeability on the premise that cAMP is linked to hormone-induced changes of water and electrolyte permeability in other tissues. In addition, dibutyryl cAMP has been found to stimulate an increase in pinocytotic vesicles in cerebral capillaries, ~z suggesting that cAMP is linked to brain capillary permeability as well. Arginine vasopressin was not active in stimulating cAMP production, but r agonists were. Furthermore, it has been shown that stimulation of the locus ceruleus, after removal of the cervical sympathetic chain, results in an increased brain capillary permeability in monkeys? 6 Presumably, this occurs via central noradrenergic outflow from the locus ceruleus to brain vessels, a pathway that has been anatomically confirmed. These experiments indicate that central AVP may influence capillary permeability either directly through non-cAMP-dependent mechanisms or indirectly, perhaps through influencing noradrenergic activity. The latter hypothesis is supported by evidence of vasopressin input to and influence on the central adrenergic system. 33 ' 35' 41 Interpretation of the ICP data is made difficult by the complexity of the intracranial volume-pressure relationship.15'16 Fluid shifts in one of the four intracranial volume compartments (intracellular, extracellular, intravascular, and intraventricular) may not be reflected by changes in ICP because of compensatory shifts in other compartments, or because, at a given point in the pressure-volume curve, very large volume changes are needed to produce measurable pressure changes. Certainly, the clearest evidence of a central AVP effect on ICP in our experiments was in unlesioned animals. In this group, ICP fell significantly by approximately 20 mm H20 after 24 hours of high-dose AVP administration. In lesioned animals, we would expect the additional intracranial volume induced by AVP (as reflected by the increased white matter water content noted above) to cause an increase in ICP. In animals treated with high-dose AVP, these expectations were met with a clinical transtentorial herniation rate of 40% versus 0% for control animals. Interestingly, the elevated pressures were not sustained beyond 18 hours, and ICP returned to control values at 24 hours in spite of the increased white matter water content measured at that time. In contrast, in the lesioned animals treated with low-dose AVP the increases in water content were not associated with a concomitant rise in ICP. Indeed, ICP was consistently lower than in the control group, closely approaching statistical significance at the 18-hour measurements. These observations --the falling ICP at 24 hours in the high-dose AVP group and the absence of any increase in ICP in the low-dose AVP group, together with the observed decrease in the ICP of AVP-treated normal animals --suggest an AVP-induced mechanism of reducing ICP which is not dependent on decreases in brain parenchymal volume. We believe this mechanism is evident even in the face of increased parenchymal volume, thus suggesting that a decrease in the intravascular and/or intraventricular volumes has occurred. This observation is supported by the literature. Noto, et al., 2z demonstrated a non-dose-dependent decrease in ICP of approximately 20 mm H20 30 minutes following single intraventricular injections of AVP ranging from 375 lag to 2.5 ng in anesthetized rabbits. In the same paper, the authors reported an increased clearance of tritiated water from the cerebral ventricles to the jugular vein following central AVP injection. These authors later showed a dose-dependent enhancement of water transport at the arachnoid granulation by both AVP and cAMP in an in vitro preparation of cat sagittal sinus. 22 Black, et al., 1 have reported that central AVP infusions caused no change in CSF production but did cause an increase in CSF absorption during ventriculocisternal perfusion in anesthetized rabbits. Our systemic measurements of mean BP and arterial blood gases offered no evidence that AVP induced changes in cerebral blood flow (or cerebral intravascular volume), and Raichle and Grubb 2s demonstrated that central AVP injections did not cause changes in cerebral blood flow in monkeysY We therefore believe that the decrease in ICP we have observed is due to decreases in CSF volume brought on by AVP. We cannot explain the large discrepancies in time and dose at which AVP decreases ICP in cats versus rabbits, 21 other than to point out the anesthetic and species differences. Certainly, it is difficult to understand the levels of CSF AVP required to decrease ICP in this study, when the proposed sites of action for this effect are extremely accessible to the CSF. Better characterization of central AVP receptors is needed.
Summary
We have performed a series of experiments to further investigate the relationship of CSF AVP to ICP, brain water content, and vasogenic edema. Experiment 1 failed to establish any effect on CSF AVP levels of either vasogenic edema alone or vasogenic edema with moderate elevations in ICP. Experiment 2 showed that a prolonged 1000-fold elevation in CSF AVP resulted in an eventual decrease in the ICP of normal cats, but did not change white matter water content. We believe that these data, together with reports in the literature, support the hypothesis that central AVP induces a reduction in CSF volume. Experiment 3 showed that prolonged 50-fold and 1000-fold elevations in CSF AVP levels resulted in a facilitation of vasogenic edema formation with variable dose-dependent responses in ICP. We have presented an argument that this facilitation is due to an AVP-induced increase in capillary permeability, recognizing that conclusive evidence is not present in our data. Finally, our measurements of mean BP, pulse rate, arterial blood gases, serum sodium concentration, and hematocrit do not support major influences of central AVP on cardiovascular or respiratory control mechanisms as reported elsewhere, 19,23,36 nor do they show evidence of functional AVP "spillover" from CSF to the systemic circulation even at these high doses.
Pharmacological levels of central vasopressin therefore appear to act on at least two sites of brain water regulation. Whether these sites can be independently influenced remains to be seen. Better understanding of central vasopressin receptors and their manipulation by newly developed agonists and antagonists have exciting clinical and experimental implications.
